Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.606 SEK | -5.31% | -8.46% | -50.73% |
Apr. 16 | Nanexa AB Announces Approval of Clinical Trial Application for NEX-22 Study Delayed | CI |
Mar. 08 | Transcript : Nanexa AB - Special Call |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-50.73% | 7.5M | |
-10.84% | 187M | |
-59.36% | 82M |
- Stock Market
- Equities
- NANEXA Stock
- News Nanexa AB
- Transcript : Nanexa AB - Special Call